Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-15-012500)

Filing Details

Accession Number:: 0001179110-15-012500
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-24 08:46:01
Reporting Period:: 2015-08-20

Filing Date:: 2015-08-24
Accepted Time:: 2015-08-24 08:46:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1159036	Halozyme Therapeutics Inc	HALO	Biological Products, (No Disgnostic Substances) (2836)	880488686

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1644348	Laurie Stelzer	C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Road San Diego CA 92121	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-08-20	10,000	$17.24	10,000	No	4	P	Indirect	By trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By trust

Footnotes

The price reported is the average weighted price. The shares were sold in multiple transactions at prices ranging from $17.21 to $17.25, inclusive. The reporting person undertakes to provide to the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were purchased.
The reporting person is co-trustee of the Gregory and Laureen Stelzer Living Trust.